Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer Screening

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

King's Daughter's Medical Center, Ashland, Kentucky, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.
Willing to participate in the QUILS Index Assessment Survey process
Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews

Exclusion criteria

Unwilling to participate in the QUILS Index Assessment Survey process
Unwilling to participate in the QUILS Audit Feedback presentations
Unwilling to participate in formative evaluation interviews

Treatment and study plan

QUILS System

Other

Implementation initiative involving statewide coalition engagement surveys, interviews, educational outreach, and collaborative activities designed to improve awareness, coordination, policy support, and implementation of equitable and high-quality lung screening programs.

Primary outcomes

Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score

Time frame: One year following study start up and initial assessment.

The QUILS Index Assessment is a program-level measure of lung cancer screening implementation quality. Scores range from 0 to 95, with a higher score indicating higher quality implementation of lung cancer screening practices. The outcome measure is the change in total QUILS Index score from Baseline to 12 months.

Study contacts

Contact information is provided by the study sponsor or research team.

Joseph Alexander, MD

CONTACT

[email protected]

8593230892

Sponsors and collaborators

Lead sponsor

Timothy Mullett

Other

Registry information

Official study title

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS System

Important dates

Study start: 2025
Primary completion: 2027
Study completion: 2028
First posted: Jun 10, 2026
Registry last updated: Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting